Its proposed mechanism is to stimulate lipolysis (the breakdown of stored fat) and to inhibit lipogenesis (the formation of new fat), apparently through -adrenergic-related pathways, while unlike full-length GH not raising IGF-1 and not impairing glucose tolerance [1] [5]
Its important for doctors and patients to know these rules
Without a substantial change in UK medicines law or the development of a fully proven and licensed non-injectable alternative for malabsorption conditions like PA, the injection will remain a Prescription-Only Medicine
Medication may be provided, only after a consultation by a licensed medical provider.
For individuals who cannot tolerate the gastrointestinal side effects of GLP-1 agonists, or who are seeking a compound with minimal systemic hormonal activity, AOD-9604's safety record is one of its few genuine selling points
5-Amino-1MQ Vial Lyophilized 5-Amino-1MQ research material for laboratory reconstitution